Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Net Margin Growth (5y) (2016 - 2024)

Analysis

Cerenome (CNSY) Net Margin Growth (5y) (2016 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn -
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn
10 Cerenome 20.42 Mn 11.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 28,350.00
Dec 31, 2023 11,531.00
Sep 30, 2023 37,941.00
Jun 30, 2023 47,639.00
Mar 31, 2023 -29,831.00
Dec 31, 2022 -246,704.00
Sep 30, 2022 -615,697.00
Mar 31, 2019 53,078.00
Dec 31, 2018 -3,390.00
Sep 30, 2018 13,865.00
Jun 30, 2018 -5,624.00
Mar 31, 2018 -11,639.00
Dec 31, 2017 -115,835.00
Sep 30, 2017 -17,781.00
Jun 30, 2017 -22,266.00
Mar 31, 2017 -65,339.00
Dec 31, 2016 -638.00
Sep 30, 2016 -34,716.00
Jun 30, 2016 -35,867.00
Mar 31, 2016 47,899.00